NCT06106919Completed
Ovarian Blockade During Fertility Preservation in Patients With Endometriosis
PFENDO : Ovarian Blockade During Fertility Preservation in Patients With Endometriosis: a Retrospective Non-inferiority Comparative Study
Source: ClinicalTrials.gov · Last updated 10 Dec 2025
Brief summary (registry, in English)
The aim of the study is to demonstrate the non-inferiority of dienogest on the number of mature oocytes collected compared with "conventional" ovarian stimulation protocols (using a GnRH agonist or antagonist), in patients with endometriosis in a fertility preservation context.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 130 (actual)
- First submitted
- 20 Oct 2023
- Start date
- 18 Dec 2023
- Primary completion date
- 3 Apr 2024
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Diseases
- Endometriosis
- NCT number
- NCT06106919
What you commit to
- Study type: Observational
- Participants enrolled: 130
- From 18 Dec 2023 to the primary completion date, 3 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- -Non-medical or medical fertility preservation excluding endometriosis
Who the study is looking for
- Patient aged between 18 and 42 inclusive
- Patient with endometriosis
- Patient who has undergone at least one cycle of ovarian stimulation for fertility preservation between June 2022 and September 2023 inclusive, using one of the protocols studied:
- GnRH agonist GnRH antagonist Dienogest
Age in the registry: 18 years to 42 years · Sex: Female
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Nîmes Coordinator of this site? Confirm its status | Nîmes | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.